The specific role of pRb in p16INK4A-mediated arrest of normal and malignant human breast cells

Cell Cycle

Volumn 11, Issue 5, 2012, Pages 1008-1013

  Bazarov, Alexey V ^a,b   Lee, Won Jae ^b   Bazarov, Irina ^b   Bosire, Moses ^b   Hines, William C ^b   Stankovich, Basha ^b   Chicas, Agustin ^c   Lowe, Scott W ^c   Yaswen, Paul ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Breast cancer; p107; p130; Retinoblastoma; Senescence

Indexed keywords

PROTEIN P107; PROTEIN P130; PROTEIN P16; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DNA REPLICATION; GROWTH INHIBITION; GROWTH RATE; HUMAN; HUMAN CELL; LIFESPAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SENESCENCE; SIGNAL TRANSDUCTION;

EID: 84863230411     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.11.5.19492     Document Type: Article

References (27)

1. Campisi J, d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007; 8:729-40; PMID:17667954; http:// dx.doi.org/10.1038/nrm2233.
2. Courtois-Cox S, Jones SL, Cichowski K. Many roads lead to oncogene-induced senescence. Oncogene 2008; 27:2801-9; PMID:18193093; http://dx.doi. org/10.1038/sj.onc.1210950.
3. Narita M, Lowe SW. Senescence comes of age. Nat Med 2005; 11:920-2; PMID:16145569; http://dx.doi. org/10.1038/nm0905-920.
4. Prieur A, Peeper DS. Cellular senescence in vivo: a barrier to tumorigenesis. Curr Opin Cell Biol 2008; 20:150-5; PMID:18353625; http://dx.doi. org/10.1016/j.ceb.2008.01.007.
5. Hornsby PJ. Senescence and lifespan. Pflugers Arch 2010; 459:291-9; PMID:19763609; http://dx.doi. org/10.1007/s00424-009-0723-6.
6. Sage J, Mulligan GJ, Attardi LD, Miller A, Chen S, Williams B, et al. Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev 2000; 14:3037- 50; PMID:11114892; http://dx.doi.org/10.1101/ gad.843200.
7. Du W, Pogoriler J. Retinoblastoma family genes. Oncogene 2006; 25:5190-200; PMID:16936737; http://dx.doi.org/10.1038/sj.onc.1209651.
8. Malumbres M, Ortega S, Barbacid M. Genetic analysis of mammalian cyclin-dependent kinases and their inhibitors. Biol Chem 2000; 381:827- 38; PMID:11076015; http://dx.doi.org/10.1515/ BC.2000.105.
9. Cobrinik D. Pocket proteins and cell cycle control. Oncogene 2005; 24:2796-809; PMID:15838516; http://dx.doi.org/10.1038/sj.onc.1208619.
10. Burkhart DL, Sage J. Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat Rev Cancer 2008; 8:671-82; PMID:18650841; http:// dx.doi.org/10.1038/nrc2399.
11. Treré D, Brighenti E, Donati G, Ceccarelli C, Santini D, Taffurelli M, et al. High prevalence of retinoblastoma protein loss in triple-negative breast cancers and its association with a good prognosis in patients treated with adjuvant chemotherapy. Ann Oncol 2009; 20:1818-23; PMID:19556322; http://dx.doi.org/10.1093/annonc/mdp209.
12. Chicas A, Wang X, Zhang C, McCurrach M, Zhao Z, Mert O, et al. Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescence. Cancer Cell 2010; 17:376-87; PMID:20385362; http://dx.doi.org/10. 1016/j.ccr.2010.01.023.
13. Bazarov AV, Van Sluis M, Hines WC, Bassett E, Beliveau A, Campeau E, et al. p16(INK4a)-mediated suppression of telomerase in normal and malignant human breast cells. Aging Cell 2010; 9:736-46; PMID:20569236; http://dx.doi.org/10. 1111/j.1474- 9726.2010.00599.x.
14. Bykov VJ, Issaeva N, Shilov A, Hultcrantz M, Pugacheva E, Chumakov P, et al. Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound. Nat Med 2002; 8:282-8; PMID:11875500; http://dx.doi.org/10.1038/ nm0302-282.
15. Narisawa-Saito M, Kiyono T. Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins. Cancer Sci 2007; 98:1505-11; PMID:17645777; http://dx.doi. org/10.1111/j.1349-7006.2007. 00546.x.
16. Yaswen P, Stampfer MR. Molecular changes accompanying senescence and immortalization of cultured human mammary epithelial cells. Int J Biochem Cell Biol 2002; 34:1382-94; PMID:12200033; http:// dx.doi.org/10.1016/S1357-2725(02) 00047-X.
17. Cip1/Waf1 in UV-irradiated and transformed cells. Oncogene 1998; 16:1333-43; PMID:9546435; http:// dx.doi.org/10.1038/sj.onc.1201897.
18. Fry DW, Harvey PJ, Keller PR, Elliott WL, Meade M, Trachet E, et al. Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts. Mol Cancer Ther 2004; 3:1427-38; PMID:15542782.
19. Viatour P, Somervaille TC, Venkatasubrahmanyam S, Kogan S, McLaughlin ME, Weissman IL, et al. Hematopoietic stem cell quiescence is maintained by compound contributions of the retinoblastoma gene family. Cell Stem Cell 2008; 3:416-28; PMID:18940733; http://dx.doi.org/10.1016/j. stem.2008.07.009.
20. Jackson JG, Pereira-Smith OM. Primary and compensatory roles for RB family members at cell cycle gene promoters that are deacetylated and downregulated in doxorubicin-induced senescence of breast cancer cells. Mol Cell Biol 2006; 26:2501-10; PMID:16537896; http://dx.doi.org/10.1128/MCB.26.7.2501- 10.2006.
21. Worku D, Jouhra F, Jiang GW, Patani N, Newbold RF, Mokbel K. Evidence of a tumour suppressive function of E2F1 gene in human breast cancer. Anticancer Res 2008; 28:2135-9; PMID:18751386.
22. Lin WC, Lin FT, Nevins JR. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev 2001; 15:1833-44; PMID:11459832.
23. Stevens C, Smith L, La Thangue NB. Chk2 activates E2F-1 in response to DNA damage. Nat Cell Biol 2003; 5:401-9; PMID:12717439; http://dx.doi. org/10.1038/ncb974.
24. Beauséjour CM, Krtolica A, Galimi F, Narita M, Lowe SW, Yaswen P, et al. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J 2003; 22:4212-22; PMID:12912919; http://dx.doi. org/10.1093/emboj/ cdg417.
25. Campeau E, Ruhl VE, Rodier F, Smith CL, Rahmberg BL, Fuss JO, et al. A versatile viral system for expression and depletion of proteins in mammalian cells. PLoS One 2009; 4:6529; PMID:19657394; http://dx.doi. org/10.1371/journal. pone.0006529.
26. Garbe J, Wong M, Wigington D, Yaswen P, Stampfer MR. Viral oncogenes accelerate conversion to immortality of cultured conditionally immortal human mammary epithelial cells. Oncogene 1999; 18:2169-80; PMID:10327063; http://dx.doi.org/10.1038/ sj.onc.1202523.
27. Finn RS, Dering J, Conklin D, Kalous O, Cohen DJ, Desai AJ, et al. PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro. Breast Cancer Res 2009; 11:77; PMID:19874578; http://dx.doi.org/10.1186/bcr2419.